BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23179960)

  • 1. Progression of β-cell dysfunction in obese youth.
    Giannini C; Caprio S
    Curr Diab Rep; 2013 Feb; 13(1):89-95. PubMed ID: 23179960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of β-Cell Function Between Overweight/Obese Adults and Adolescents Across the Spectrum of Glycemia.
    Chen ME; Chandramouli AG; Considine RV; Hannon TS; Mather KJ
    Diabetes Care; 2018 Feb; 41(2):318-325. PubMed ID: 29183909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet function in obese adolescents.
    Giannini C; Caprio S
    Diabetes Obes Metab; 2012 Oct; 14 Suppl 3():40-5. PubMed ID: 22928563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon.
    Tfayli H; Arslanian S
    Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):165-74. PubMed ID: 19466209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin sensitivity across the lifespan from obese adolescents to obese adults with impaired glucose tolerance: Who is worse off?
    Arslanian S; Kim JY; Nasr A; Bacha F; Tfayli H; Lee S; Toledo FGS
    Pediatr Diabetes; 2018 Mar; 19(2):205-211. PubMed ID: 28726334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite?
    Malone JI; Hansen BC
    Pediatr Diabetes; 2019 Feb; 20(1):5-9. PubMed ID: 30311716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of type 2 diabetes mellitus in the obese adolescent: a growing challenge.
    Caprio S
    Endocr Pract; 2012; 18(5):791-5. PubMed ID: 23047931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in insulin sensitivity, pancreatic beta cell function and circulating adiponectin across glucose tolerance status in Thai obese and non-obese women.
    Chailurkit LO; Chanprasertyothin S; Jongjaroenprasert W; Ongphiphadhanakul B
    Endocrine; 2008 Feb; 33(1):84-9. PubMed ID: 18389389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of type 2 diabetes in children and adolescents.
    Weiss R; Caprio S
    Minerva Med; 2006 Jun; 97(3):263-9. PubMed ID: 16855520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic high-fat diet in fathers programs β-cell dysfunction in female rat offspring.
    Ng SF; Lin RC; Laybutt DR; Barres R; Owens JA; Morris MJ
    Nature; 2010 Oct; 467(7318):963-6. PubMed ID: 20962845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel canine models of obese prediabetes and mild type 2 diabetes.
    Ionut V; Liu H; Mooradian V; Castro AV; Kabir M; Stefanovski D; Zheng D; Kirkman EL; Bergman RN
    Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E38-48. PubMed ID: 19843874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review.
    Inaishi J; Saisho Y
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33339276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of β-cell dysfunction and insulin resistance correlating obesity with type 2 diabetes: A cross-sectional study.
    Liu J; Wang Y; Hu Y; Leng S; Wang G
    J Diabetes Complications; 2016 Jul; 30(5):898-902. PubMed ID: 27012460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different β-cell secretory phenotype in non-obese compared to obese early type 2 diabetes.
    Gudipaty L; Rosenfeld NK; Fuller CS; Cuchel M; Rickels MR
    Diabetes Metab Res Rev; 2020 Jul; 36(5):e3295. PubMed ID: 32017362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology of insulin resistance in youth with type 2 diabetes.
    Cree-Green M; Triolo TM; Nadeau KJ
    Curr Diab Rep; 2013 Feb; 13(1):81-8. PubMed ID: 23135953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta cell function and insulin sensitivity in obese youth with maturity onset diabetes of youth mutations vs type 2 diabetes in TODAY: Longitudinal observations and glycemic failure.
    Arslanian S; El Ghormli L; Haymond MH; Chan CL; Chernausek SD; Gandica RG; Gubitosi-Klug R; Levitsky LL; Siska M; Willi SM;
    Pediatr Diabetes; 2020 Jun; 21(4):575-585. PubMed ID: 32064729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Reduced Incretin Effect Mediated by the rs7903146 Variant in the
    Galderisi A; Tricò D; Pierpont B; Shabanova V; Samuels S; Dalla Man C; Galuppo B; Santoro N; Caprio S
    Diabetes Care; 2020 Oct; 43(10):2553-2563. PubMed ID: 32788279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescents.
    Tricò D; Natali A; Arslanian S; Mari A; Ferrannini E
    JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDY.
    Ferjan S; Janez A; Jensterle M
    Endocr Pract; 2018 Jan; 24(1):69-77. PubMed ID: 29144805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-cells in youth with impaired glucose tolerance or early type 2 diabetes secrete more insulin and are more responsive than in adults.
    Utzschneider KM; Tripputi MT; Kozedub A; Mather KJ; Nadeau KJ; Edelstein SL; Hannon TS; Arslanian SA; Cree-Green M; Buchanan TA; Caprio S; Mari A;
    Pediatr Diabetes; 2020 Dec; 21(8):1421-1429. PubMed ID: 32902875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.